Related Experiment Video
Updated: Jul 14, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Coronary calcification in patients presenting with acute coronary syndromes: insights from the MATRIX trial
Jorge Sanz-Sanchez1,2, Hector M Garcia-Garcia3, Mattia Branca4
1Cardiology Department, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Insights
Severe coronary calcification in acute coronary syndromes (ACS) patients is linked to worse outcomes, including higher rates of major adverse cardiovascular events (MACE) and mortality, regardless of treatment strategy.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Coronary calcification assessment is crucial in acute coronary syndromes (ACS).
- The impact of severe coronary calcification on clinical outcomes across revascularization strategies in ACS patients is understudied.
- Coronary angiography is a key diagnostic tool for evaluating coronary calcification.
Purpose of the Study:
- To investigate the role of coronary calcification, detected via coronary angiography, in patients presenting with acute coronary syndromes (ACS).
- To evaluate the association between severe coronary calcification and clinical outcomes in the entire spectrum of ACS patients.
- To determine if coronary calcification influences outcomes independently of revascularization strategy.
Main Methods:
- Post hoc analysis of the MATRIX programme, including 7446 patients with available coronary calcification data.
- Coronary calcification severity was assessed by coronary angiography.
- Primary endpoint: major adverse cardiovascular events (MACE) – all-cause mortality, myocardial infarction (MI), or stroke at 365 days.
Main Results:
- 11.7% of patients had severe coronary calcification.
- Severe calcification was associated with fewer percutaneous coronary interventions and more coronary artery bypass grafting or medical therapy-only.
- Patients with severe calcification had significantly higher 1-year MACE (27.1% vs. 15%), mortality (8.6% vs. 3.7%), and MI (20.1% vs. 11.5%) rates compared to those without severe calcification.
Conclusions:
- Severe coronary calcification in ACS patients is independently associated with significantly worse clinical outcomes.
- This association persists irrespective of the chosen management or revascularization strategy.
- Findings highlight the prognostic significance of coronary calcification in ACS management.
Aims:
The role of coronary calcification on clinical outcomes among different revascularization strategies in patients presenting with acute coronary syndromes (ACSs) has been rarely investigated. The aim of this investigation is to evaluate the role of coronary calcification, detected by coronary angiography, in the whole spectrum of patients presenting with acute ACS.
Methods And Results:
The present study was a post hoc analysis of the MATRIX programme. The primary endpoint was major adverse cardiovascular events (MACE), defined as the composite of all-cause mortality, myocardial infarction (MI), or stroke up to 365 days. Among the 8404 patients randomized in the MATRIX trial, data about coronary calcification were available in 7446 (88.6%) and therefore were included in this post hoc analysis. Overall, 875 patients (11.7%) presented with severe coronary calcification, while 6571 patients (88.3%) did not present severe coronary calcification on coronary angiography. Fewer patients with severe coronary calcification underwent percutaneous coronary intervention whereas coronary artery bypass grafting or medical therapy-only was more frequent compared with patients without severe calcification. At 1-year follow-up, MACE occurred in 237 (27.1%) patients with severe calcified coronary lesions and 985 (15%) patients without severe coronary calcified lesions [hazard ratio (HR) 1.91; 95% confidence interval (CI) 1.66-2.20, P < 0.001]. All-cause mortality was 8.6% in patients presenting with and 3.7% in those without severe coronary calcification (HR 2.38, 1.84-3.09, P < 0.001). Patients with severe coronary calcification incurred higher rate of MI (20.1% vs. 11.5%, HR 1.81; 95% CI 1.53-2.1, P < 0.001) and similar rate of stroke (0.8% vs. 0.6%, HR 1.35; 95% CI 0.61-3.02, P = 0.46).
Conclusion:
Patients with ACS and severe coronary calcification, as compared to those without, are associated with worse clinical outcomes irrespective of the management strategy.
More Related Videos
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology